Authors:
TAM SH
KELLY JJ
WILLIAMSON PM
WHITWORTH JA
Citation: Sh. Tam et al., REFLEX SYMPATHETIC FUNCTION IN CORTISOL-INDUCED HYPERTENSION IN HUMANS, Clinical and experimental hypertension, 19(4), 1997, pp. 479-493
Authors:
OWADA A
NONOGUCHI H
TERADA Y
MARUMO F
TOMITA K
Citation: A. Owada et al., EFFECTS OF QUINAPRIL HYDROCHLORIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND IMPAIRED RENAL-FUNCTION, Clinical and experimental hypertension, 19(4), 1997, pp. 495-502
Authors:
NISHIKIMI T
MORIMOTO A
ISHIKAWA K
SAITO Y
KANGAWA K
MATSUO H
KITAMURA K
TAKISHITA S
MATSUOKA H
Citation: T. Nishikimi et al., DIFFERENT SECRETION PATTERNS OF ADRENOMEDULLIN, BRAIN NATRIURETIC PEPTIDE, AND ATRIAL-NATRIURETIC-PEPTIDE DURING EXERCISE IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS, Clinical and experimental hypertension, 19(4), 1997, pp. 503-518
Authors:
YAMADA Y
TSURITANI I
ISHIZAKI M
IKAI E
ISHIDA M
NOBORISAKA Y
HONDA R
Citation: Y. Yamada et al., SERUM GAMMA-GLUTAMYL-TRANSFERASE LEVELS AND BLOOD-PRESSURE FALLS AFTER ALCOHOL MODERATION, Clinical and experimental hypertension, 19(3), 1997, pp. 249-268
Authors:
LIPKE DW
NEWMAN PS
TOFIQ S
GUO H
ARCOT SS
AZIZ SM
OLSON JW
SOLTIS EE
Citation: Dw. Lipke et al., MULTIPLE POLYAMINE REGULATORY PATHWAYS CONTROL COMPENSATORY CARDIOVASCULAR HYPERTROPHY IN COARCTATION HYPERTENSION, Clinical and experimental hypertension, 19(3), 1997, pp. 269-295
Authors:
LIPKE DW
NEWMAN PS
TOFIQ S
AZIZ SM
SOLTIS EE
Citation: Dw. Lipke et al., EFLORNITHINE ALTERS CHANGES IN VASCULAR RESPONSIVENESS ASSOCIATED WITH COARCTATION HYPERTENSION, Clinical and experimental hypertension, 19(3), 1997, pp. 297-312
Citation: Ms. Mozaffari et al., RENAL-FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS WITH INSULIN-EXACERBATED HYPERTENSION, Clinical and experimental hypertension, 19(3), 1997, pp. 313-329
Authors:
GUAGNANO MT
PALITTI VP
MERLITTI D
CARRABS C
SANTUCCI E
SENSI S
Citation: Mt. Guagnano et al., TRANSDERMAL CLONIDINE THERAPY AND BLOOD-PRESSURE NOCTURNAL FALL IN MILD HYPERTENSIVE MALE-SUBJECTS, Clinical and experimental hypertension, 19(3), 1997, pp. 331-341
Authors:
MEDINACAMPOS ON
PEDRAZACHAVERRI J
CORREAROTTER R
IBARRARUBIO ME
Citation: On. Medinacampos et al., REGULATION OF HEPATIC ANGIOTENSINOGEN GENE-EXPRESSION IN NEPHROTIC RATS, Clinical and experimental hypertension, 19(3), 1997, pp. 343-362
Authors:
KOMIYAMA Y
KIMURA Y
NISHIMURA N
HARA K
MORI T
OKUDA K
MUNAKATA M
MASUDA M
MURAKAMI T
TAKAHASHI H
Citation: Y. Komiyama et al., VASODEPRESSOR EFFECTS OF EXERCISE ARE ACCOMPANIED BY REDUCED CIRCULATING OUABAIN-LIKE IMMUNOREACTIVITY AND NORMALIZATION OF NITRIC-OXIDE SYNTHESIS, Clinical and experimental hypertension, 19(3), 1997, pp. 363-372
Authors:
DEQUATTRO V
LEE DP
MESSERLI F
ALAGONA P
ANGELO J
HERKENDER C
APPLEGATE W
FOWLER N
BENZ JR
BOYDEN T
PAMATER R
CUTLER N
LU ZW
DOHERTY JE
BRANDT D
FELICETTA JV
JOHNSON J
LEFOR N
GLASSER S
HAWKINS C
GOLDSTEIN R
CARLSON K
COOPER W
GRAY JM
HORWITZ L
CLEGG L
IVANHOE RJ
WALKER P
JAIN A
MCMAHON FG
VARGAS R
GOTZKOWSKY S
KAIHLANEN PM
RUFF D
ZUNKER R
LEVINE J
MCGUIRE R
MASSIE B
AMMON S
MILLER W
LUCKASEN G
COLLINS F
NEWMAN BG
NOBLE R
PASTER R
COULTHARD D
GEHIN B
PLESKOW W
PETERSON J
PUNZI H
RIESS J
WALKER K
VENKATA C
RAM S
REEVES R
HALL J
INOUE S
JACQUES P
SAVRAN S
HESS T
COWAN B
SERFER HM
SHAW D
SILBERMAN H
ROSEN J
SCHAFFHAUSEN L
MILANES M
GABLES C
SINGH B
RABANAL P
SNYDER F
SOLER J
STEIN W
OSHRAIN C
BUDD J
ABBOTT R
STRAUSS M
ALSTADT K
CARTER P
WEBER M
WEIR M
MUELLER C
URICK A
WOLFSON PO
DUNLAP S
WIPPLE D
BOHLNER N
WOOD B
MCGURREN N
Citation: V. Dequattro et al., EFFICACY OF COMBINATION THERAPY WITH TRANDOLAPRIL AND VERAPAMIL-SR INPRIMARY HYPERTENSION - A 4X4-TRIAL DESIGN, Clinical and experimental hypertension, 19(3), 1997, pp. 373-387
Citation: Dp. Healy et Da. Orourke, REGULATION OF DOPAMINE-1A (D-1A) RECEPTOR GENE-TRANSCRIPTION, Clinical and experimental hypertension, 19(1-2), 1997, pp. 1-13
Citation: F. Amenta et Mf. Lokhandwala, PROCEEDINGS OF THE 6TH INTERNATIONAL-CONFERENCE ON PERIPHERAL DOPAMINE - PREFACE, Clinical and experimental hypertension, 19(1-2), 1997, pp. 7-7
Authors:
JOSE PA
DRAGO J
ACCILI D
EISNER GM
FELDER RA
Citation: Pa. Jose et al., TRANSGENIC MICE TO STUDY THE ROLE OF DOPAMINE-RECEPTORS IN CARDIOVASCULAR FUNCTION, Clinical and experimental hypertension, 19(1-2), 1997, pp. 15-25
Citation: F. Amenta, LIGHT-MICROSCOPE AUTORADIOGRAPHY OF PERIPHERAL DOPAMINE-RECEPTOR SUBTYPES, Clinical and experimental hypertension, 19(1-2), 1997, pp. 27-41
Authors:
VIEIRACOELHO MA
GOMES P
SERRAO MP
SOARESDASILVA P
Citation: Ma. Vieiracoelho et al., RENAL AND INTESTINAL AUTOCRINE MONOAMINERGIC SYSTEMS - DOPAMINE VERSUS 5-HYDROXYTRYPTAMINE, Clinical and experimental hypertension, 19(1-2), 1997, pp. 43-58
Citation: A. Ricci et al., EXPRESSION OF DOPAMINE-RECEPTORS IN IMMUNE ORGANS AND CIRCULATING IMMUNE CELLS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 59-71
Authors:
PINTODOO PC
CHIBALIN AV
KATZ AI
SOARESDASILVA P
BERTORELLO AM
Citation: Pc. Pintodoo et al., SHORT-TERM VS SUSTAINED INHIBITION OF PROXIMAL TUBULE NA,K-ATPASE ACTIVITY BY DOPAMINE - CELLULAR MECHANISMS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 73-86
Citation: Ad. Baines et R. Drangova, REGULATION OF SODIUM-TRANSPORT BY ENDOGENOUS DOPAMINE PRODUCTION IN PROXIMAL TUBULAR AND OK CELLS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 87-91
Citation: Zq. Wang et al., PREFERENTIAL RELEASE OF RENAL DOPAMINE INTO THE TUBULE LUMEN - EFFECTOF CHRONIC SODIUM LOADING, Clinical and experimental hypertension, 19(1-2), 1997, pp. 107-116
Citation: O. Iimura et al., COMPARATIVE HYPERTENSIONOLOGY RENAL DOPAMINERGIC ACTIVITY IN EXPERIMENTAL HYPERTENSIVE RATS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 117-130
Citation: T. Hussain et Mf. Lokhandwala, DOPAMINE-1 RECEPTOR G-PROTEIN COUPLING AND THE INVOLVEMENT OF PHOSPHOLIPASE-A2 IN DOPAMINE-1 RECEPTOR-MEDIATED CELLULAR SIGNALING MECHANISMS IN THE PROXIMAL TUBULES OF SHR, Clinical and experimental hypertension, 19(1-2), 1997, pp. 131-140
Authors:
HABUCHI Y
TANAKA H
YAMAMOTO T
KOMORI T
NISHIO M
YOSHIMURA M
Citation: Y. Habuchi et al., THE MECHANISMS UNDERLYING HEART STIMULATION BY DOPAMINE, WITH SPECIALREFERENCE TO DIRECT AND INDIRECT BETA-ADRENOCEPTOR STIMULATION, Clinical and experimental hypertension, 19(1-2), 1997, pp. 141-154
Citation: Ds. Goldstein et C. Holmes, METABOLIC-FATE OF THE SYMPATHONEURAL IMAGING AGENT 6-[F-18]FLUORODOPAMINE IN HUMANS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 155-161